↓ Skip to main content

Cochrane Database of Systematic Reviews

Levodopa for the treatment of restless legs syndrome

Overview of attention for article published in Cochrane database of systematic reviews, February 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
wikipedia
5 Wikipedia pages

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
91 Mendeley
connotea
1 Connotea
Title
Levodopa for the treatment of restless legs syndrome
Published in
Cochrane database of systematic reviews, February 2011
DOI 10.1002/14651858.cd005504.pub2
Pubmed ID
Authors

Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann, Magdolna Hornyak

Abstract

Levodopa plus dopamine decarboxylase inhibitor is a common treatment for restless legs syndrome (RLS).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 22%
Student > Bachelor 11 12%
Researcher 8 9%
Student > Postgraduate 6 7%
Student > Ph. D. Student 5 5%
Other 12 13%
Unknown 29 32%
Readers by discipline Count As %
Medicine and Dentistry 32 35%
Nursing and Health Professions 7 8%
Psychology 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Social Sciences 3 3%
Other 7 8%
Unknown 33 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2022.
All research outputs
#6,503,489
of 23,056,273 outputs
Outputs from Cochrane database of systematic reviews
#8,301
of 12,359 outputs
Outputs of similar age
#52,300
of 199,694 outputs
Outputs of similar age from Cochrane database of systematic reviews
#55
of 121 outputs
Altmetric has tracked 23,056,273 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 12,359 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.0. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,694 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.